4More than anti-malarial agents: therapeutic potential of artemisinins in neurodegenerationREVIiEW1494-1498
8Neuromodulation and ablation with focused ultrasound - toward the future of noninvasive brain therapyPERSPECTIVvE1509-1510
9Strategies to promote the maturation of ALS-associated SOD1 mutants:small molecules return to the foldPERSPECTIVvE1511-1512
10Cell signaling associated with internalization of 67 kDa laminin receptor (67LR) by soluble laminin and its implication for protection against neurodegenerative diseasesPERSPECTIVvE1513-1514
11Spinal cord organoids add an extra dimension to traditional motor neuron culturesPERSPECTIVvE1515-1516
12Preclinical concepts and results with the GABAA antagonist S44819 in a mouse model of middle cerebral artery occlusionPERSPECTIVvE1517-1518
13Neuroprotective effect of Neuro-EPO in neurodegenerative diseases: "Alea jacta est"PERSPECTIVvE1519-1521
14Adipose-derived stem cell conditioned medium for the treatment of amyotrophic lateral sclerosis:pre-clinical evidence and potential for clinical applicationPERSPECTIVvE1522-1524
15Therapeutic potential of AMPA receptor antagonist perampanel against cerebral ischemia: beyond epileptic disorderPERSPECTIVvE1525-1526
17Sodium butyrate prevents radiation-induced cognitive impairment by restoring pCREB/BDNF expressionRESEARCH ARTICLE1530-1535
18Pretreated Oenanthe Javanica extract increases anti-inflammatory cytokines, attenuates gliosis, and protects hippocampal neurons following transient global cerebral ischemia in gerbilsRESEARCH ARTICLE1536-1543
19Age-related changes in resting-state functional connectivity in older adultsRESEARCH ARTICLE1544-1555
20Traumatic axonal injury of the cingulum in patients with mild traumatic brain injury: a diffusion tensor tractography studyRESEARCH ARTICLE1556-1561
